@article{5cd319dbb8074c5e9a43b05d014ca867,
title = "Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767)",
abstract = "In the original article, there was an error. The IRB Number of our article, “IRB No: 202100961B0”, was typed mistakenly as “IRB No: 20210096B0”. A correction has been made to the last sentence of the Materials and Methods, Patients and the Ethics Statement”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.",
keywords = "hepatocellular carcinoma, lenvatinib, progression-free survival, propensity score (PS) matching (PSM), sorafenib",
author = "Kuo, {Yuan Hung} and Lu, {Sheng Nan} and Chen, {Yen Yang} and Kee, {Kwong Ming} and Yen, {Yi Hao} and Hung, {Chao Hung} and Hu, {Tsung Hui} and Chen, {Chien Hung} and Wang, {Jing Houng}",
note = "Publisher Copyright: {\textcopyright} 2021 Kuo, Lu, Chen, Kee, Yen, Hung, Hu, Chen and Wang.",
year = "2021",
month = dec,
day = "14",
doi = "10.3389/fonc.2021.823960",
language = "英语",
volume = "11",
journal = "Frontiers in Oncology",
issn = "2234-943X",
}